Brief: Accelerate Diagnostics reports Q2 results
Aug 15 (Reuters) - Accelerate Diagnostics Inc AXDX.O :
* ACCELERATE DIAGNOSTICS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS
* Q2 SALES ROSE 39 PERCENT TO $3.9 MILLION
* Q2 LOSS PER SHARE $0.23
Source text for Eikon: ID:nPn2wNN0pa
Further company coverage: AXDX.O
Recent news on Accelerate Diagnostics
See all newsBrief: Accelerate Diagnostics Files For Chapter 11 Protection And Agrees To Terms To Sell Substantially All Assets
Brief: Accelerate Diagnostics files for Chapter 11 bankruptcy
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview
Accelerate Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary
Accelerate Diagnostics Inc expected to post a loss of 49 cents a share - Earnings Preview